ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 21 filers reported holding ARCA BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,174 | -1.0% | 20,982 | 0.0% | 0.00% | – |
Q2 2023 | $42,593 | +2.0% | 20,982 | 0.0% | 0.00% | – |
Q1 2023 | $41,754 | +0.6% | 20,982 | +19.8% | 0.00% | – |
Q4 2022 | $41,515 | +15.3% | 17,517 | 0.0% | 0.00% | – |
Q3 2022 | $36,000 | -18.2% | 17,517 | 0.0% | 0.00% | – |
Q2 2022 | $44,000 | +10.0% | 17,517 | 0.0% | 0.00% | – |
Q1 2022 | $40,000 | +5.3% | 17,517 | 0.0% | 0.00% | – |
Q4 2021 | $38,000 | -26.9% | 17,517 | 0.0% | 0.00% | – |
Q3 2021 | $52,000 | -14.8% | 17,517 | 0.0% | 0.00% | – |
Q2 2021 | $61,000 | -4.7% | 17,517 | 0.0% | 0.00% | – |
Q1 2021 | $64,000 | -8.6% | 17,517 | -0.0% | 0.00% | – |
Q4 2020 | $70,000 | – | 17,525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SG3 Management, LLC | 100,000 | $249,000 | 0.03% |
Murchinson Ltd. | 50,593 | $126,000 | 0.02% |
Marquette Asset Management, LLC | 17,318 | $43,000 | 0.01% |
SG3 Management, LLC | 22,706 | $57,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $117,000 | 0.00% |
Tekla Capital Management LLC | 32,461 | $81,000 | 0.00% |
BAILARD, INC. | 35,000 | $87,000 | 0.00% |
GROUP ONE TRADING, L.P. | 131,501 | $327,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 10,238 | $25,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 882,900 | $2,198,000 | 0.00% |